# Spinal Morphine for Patients With Obstructive Sleep Apnea

> **NCT01790971** · NA · SUSPENDED · sponsor: **University Health Network, Toronto** · enrollment: 40 (estimated)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Intrathecal Morphine
- **DRUG:** No Intrathecal Morphine

## Key facts

- **NCT ID:** NCT01790971
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-01
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** competing studies
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01790971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01790971, "Spinal Morphine for Patients With Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01790971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*